Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.43 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.43 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.43 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.43 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | GALR3 | O60755 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10772031 | 0.86 | ALOX15 (0.43) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL10607716 | 0.85 | ALOX15 (0.42) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL39120 | 0.83 | — | — | |
| SCHEMBL7547957 | 0.81 | — | — | |
| SCHEMBL28863377 | 0.80 | CHRM5 (0.34) | ALOX15CHRNB2CHRNA4CHRM5CHRM1 | |
| SCHEMBL28719241 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL10593004 | 0.79 | ALOX15 (0.44) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| Chloroform SCHEMBL5063518 | 0.79 | ALOX15 (0.48) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 | |
| SCHEMBL263908 | 0.78 | TDP1 (0.48) | ALDH1A1CHRNB2CHRNA4CHRM5CHRM1 | |
| SCHEMBL27529959 | 0.78 | ALOX15 (0.47) | ALOX15ALDH1A1CHRNB2CHRNA4CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834425-B2 | Full continuous-flow preparation method of vitamin B1 | FUDAN UNIVERSITY (CN) | 2023-12-05 | — | — | US | claimed |
| CN-116283952-A | Vitamin B 1 Is a fully continuous flow preparation method | 复旦大学 | 2023-06-23 | — | — | CN | claimed |
| US-20230183196-A1 | FULL CONTINUOUS-FLOW PREPARATION METHOD OF VITAMIN B1 | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | claimed |
| US-11618727-B2 | Method for preparing 3-chloro-4-oxopentyl acetate using fully continuous-flow micro-reaction system | FUDAN UNIVERSITY (CN) | 2023-04-04 | — | — | US | claimed |
| CN-113105410-B | Preparation method of 4-methyl-5- (2-acetoxyethyl) thiazole | 山东吉田香料股份有限公司 | 2022-06-10 | — | — | CN | claimed |
| US-20210355070-A1 | METHOD FOR PREPARING 3-CHLORO-4-OXOPENTYL ACETATE USING FULLY CONTINUOUS-FLOW MICRO-REACTION SYSTEM | FUDAN UNIVERSITY (CN) | 2021-11-18 | — | — | US | claimed |
| CN-113105410-A | Preparation method of 4-methyl-5- (2-acetoxyethyl) thiazole | 山东吉田香料股份有限公司 | 2021-07-13 | — | — | CN | claimed |
| CN-111635375-A | Synthetic method of thiazoie | 昆山亚香香料股份有限公司 | 2020-09-08 | — | — | CN | claimed |
| US-20110178300-A1 | NOVEL SYNTHESIS OF SUBSTITUTED 4-AMINO-PYRIMIDINES | DSM IP ASSETS B.V. (NL) | 2011-07-21 | — | — | US | claimed |
| EP-2307355-A1 | Novel synthesis of substituted 4-amino-pyrimidines | DSM IP Assets B.V. (NL) | 2011-04-13 | — | — | EP | claimed |
| WO-2010010113-A1 | Novel synthesis of substituted 4-amino-pyrimidines | DSM IP ASSETS B.V. (NL) | 2010-01-28 | — | — | WO | claimed |
| US-20080242863-A1 | Process For the Manufacture of a Precursor of Vitamin B1 | DSM IP ASSETS B.V. (NL) | 2008-10-02 | — | — | US | claimed |
| EP-1841745-B1 | PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1 | DSM IP ASSETS BV (NL) | 2008-06-04 | — | — | EP | claimed |
| EP-1841745-A2 | PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1 | DSMIP Assets B.V. (NL) | 2007-10-10 | — | — | EP | claimed |
| EP-1753734-A1 | NITRIC OXIDE DONORS AND USES THEREOF | RENOPHARM LTD. (IL) | 2007-02-21 | — | — | EP | claimed |
| US-20070021382-A1 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2007-01-25 | — | — | US | claimed |
| WO-2006079504-A2 | PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1 | DSM IP ASSETS B.V. (NL) | 2006-08-03 | — | — | WO | claimed |
| WO-2005105765-A1 | NITRIC OXIDE DONORS AND USES THEREOF | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | claimed |
| US-4146454-A | EXCITATION, MOBILIZERS, INITIATORS | HABER INSTRUMENTS, INC. (US) | 1979-03-27 | — | — | US | claimed |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2025064718-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2025-03-27 | — | — | WO | disclosed |
| CN-111635375-B | Method for synthesizing thiothiazole | 昆山亚香香料股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-111635375-B | Method for synthesizing thiothiazole | 昆山亚香香料股份有限公司 | 2024-06-04 | — | — | CN | disclosed |
| US-11834425-B2 | Full continuous-flow preparation method of vitamin B1 | FUDAN UNIVERSITY (CN) | 2023-12-05 | — | — | US | disclosed |
| US-11834425-B2 | Full continuous-flow preparation method of vitamin B1 | FUDAN UNIVERSITY (CN) | 2023-12-05 | — | — | US | disclosed |
| US-11834425-B2 | Full continuous-flow preparation method of vitamin B1 | FUDAN UNIVERSITY (CN) | 2023-12-05 | — | — | US | disclosed |
| CN-116283952-A | Vitamin B 1 Is a fully continuous flow preparation method | 复旦大学 | 2023-06-23 | — | — | CN | disclosed |
| US-20230183196-A1 | FULL CONTINUOUS-FLOW PREPARATION METHOD OF VITAMIN B1 | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183196-A1 | FULL CONTINUOUS-FLOW PREPARATION METHOD OF VITAMIN B1 | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| US-20230183196-A1 | FULL CONTINUOUS-FLOW PREPARATION METHOD OF VITAMIN B1 | FUDAN UNIVERSITY (CN) | 2023-06-15 | — | — | US | disclosed |
| US-11618727-B2 | Method for preparing 3-chloro-4-oxopentyl acetate using fully continuous-flow micro-reaction system | FUDAN UNIVERSITY (CN) | 2023-04-04 | — | — | US | disclosed |
| US-11618727-B2 | Method for preparing 3-chloro-4-oxopentyl acetate using fully continuous-flow micro-reaction system | FUDAN UNIVERSITY (CN) | 2023-04-04 | — | — | US | disclosed |
| US-11618727-B2 | Method for preparing 3-chloro-4-oxopentyl acetate using fully continuous-flow micro-reaction system | FUDAN UNIVERSITY (CN) | 2023-04-04 | — | — | US | disclosed |
| CN-113105410-B | Preparation method of 4-methyl-5- (2-acetoxyethyl) thiazole | 山东吉田香料股份有限公司 | 2022-06-10 | — | — | CN | disclosed |
| US-20210355070-A1 | METHOD FOR PREPARING 3-CHLORO-4-OXOPENTYL ACETATE USING FULLY CONTINUOUS-FLOW MICRO-REACTION SYSTEM | FUDAN UNIVERSITY (CN) | 2021-11-18 | — | — | US | disclosed |
| US-20210355070-A1 | METHOD FOR PREPARING 3-CHLORO-4-OXOPENTYL ACETATE USING FULLY CONTINUOUS-FLOW MICRO-REACTION SYSTEM | FUDAN UNIVERSITY (CN) | 2021-11-18 | — | — | US | disclosed |
| US-20210355070-A1 | METHOD FOR PREPARING 3-CHLORO-4-OXOPENTYL ACETATE USING FULLY CONTINUOUS-FLOW MICRO-REACTION SYSTEM | FUDAN UNIVERSITY (CN) | 2021-11-18 | — | — | US | disclosed |
| CN-113105410-A | Preparation method of 4-methyl-5- (2-acetoxyethyl) thiazole | 山东吉田香料股份有限公司 | 2021-07-13 | — | — | CN | disclosed |
| CN-111635375-A | Synthetic method of thiazoie | 昆山亚香香料股份有限公司 | 2020-09-08 | — | — | CN | disclosed |
| CN-111635375-A | Synthetic method of thiazoie | 昆山亚香香料股份有限公司 | 2020-09-08 | — | — | CN | disclosed |
| EP-2937331-B1 | A PROCESS FOR PREPARING AN INTERMEDIATE OF VITAMIN B1 | DSM IP ASSETS BV (NL) | 2017-06-21 | — | — | EP | disclosed |
| EP-2937331-B1 | A PROCESS FOR PREPARING AN INTERMEDIATE OF VITAMIN B1 | DSM IP ASSETS BV (NL) | 2017-06-21 | — | — | EP | disclosed |
| EP-2937331-A1 | A PROCESS FOR PREPARING AN INTERMEDIATE OF VITAMIN B1 | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | disclosed |
| EP-2937331-A1 | A PROCESS FOR PREPARING AN INTERMEDIATE OF VITAMIN B1 | DSM IP Assets B.V. (NL) | 2015-10-28 | — | — | EP | disclosed |
| US-9108925-B2 | Process for the manufacture of a precursor of vitamin B1 | DSM IP ASSETS B.V. (NL) | 2015-08-18 | — | — | US | disclosed |
| EP-2307355-B1 | Novel synthesis of substituted 4-amino-pyrimidines | DSM IP ASSETS BV (NL) | 2013-11-06 | — | — | EP | disclosed |
| US-8252927-B2 | Synthesis of substituted 4-amino-pyrimidines | DSM IP ASSETS B.V. (NL) | 2012-08-28 | — | — | US | disclosed |
| US-8134010-B2 | 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease | RENOPHARM LTD. (IL) | 2012-03-13 | — | — | US | disclosed |
| US-8134010-B2 | 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease | RENOPHARM LTD. (IL) | 2012-03-13 | — | — | US | disclosed |
| US-8134010-B2 | 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease | RENOPHARM LTD. (IL) | 2012-03-13 | — | — | US | disclosed |
| US-20110178300-A1 | NOVEL SYNTHESIS OF SUBSTITUTED 4-AMINO-PYRIMIDINES | DSM IP ASSETS B.V. (NL) | 2011-07-21 | — | — | US | disclosed |
| US-7968575-B2 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2011-06-28 | — | — | US | disclosed |
| US-7968575-B2 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2011-06-28 | — | — | US | disclosed |
| US-7968575-B2 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2011-06-28 | — | — | US | disclosed |
| EP-2307355-A1 | Novel synthesis of substituted 4-amino-pyrimidines | DSM IP Assets B.V. (NL) | 2011-04-13 | — | — | EP | disclosed |
| US-7879885-B2 | such as N-(2-Amino-6-methylpyridin-3-ylmethyl)-N-{2-[2-[(2-amino-6-methyl-pyridin-3-ylmethyl)formylamino]-1-(2-hydroxyethyl)-propenyldisulfanyl]-4-hydroxy-1-methylbut-1-enyl}formamide, used for inhibiting cell proliferation and tumor cell growth, stimulating apoptosis in tumor cells and treating cancer | ARRAY BIOPHARMA, INC. (US) | 2011-02-01 | — | — | US | disclosed |
| US-7879885-B2 | such as N-(2-Amino-6-methylpyridin-3-ylmethyl)-N-{2-[2-[(2-amino-6-methyl-pyridin-3-ylmethyl)formylamino]-1-(2-hydroxyethyl)-propenyldisulfanyl]-4-hydroxy-1-methylbut-1-enyl}formamide, used for inhibiting cell proliferation and tumor cell growth, stimulating apoptosis in tumor cells and treating cancer | ARRAY BIOPHARMA, INC. (US) | 2011-02-01 | — | — | US | disclosed |
| US-7879885-B2 | such as N-(2-Amino-6-methylpyridin-3-ylmethyl)-N-{2-[2-[(2-amino-6-methyl-pyridin-3-ylmethyl)formylamino]-1-(2-hydroxyethyl)-propenyldisulfanyl]-4-hydroxy-1-methylbut-1-enyl}formamide, used for inhibiting cell proliferation and tumor cell growth, stimulating apoptosis in tumor cells and treating cancer | ARRAY BIOPHARMA, INC. (US) | 2011-02-01 | — | — | US | disclosed |
| WO-2010010113-A1 | Novel synthesis of substituted 4-amino-pyrimidines | DSM IP ASSETS B.V. (NL) | 2010-01-28 | — | — | WO | disclosed |
| US-7579477-B2 | Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2009-08-25 | — | — | US | disclosed |
| US-7579477-B2 | Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2009-08-25 | — | — | US | disclosed |
| US-7579477-B2 | Thiazole-based nitric oxide donors having alkyl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2009-08-25 | — | — | US | disclosed |
| US-20090209554-A1 | Thiazoliums as transketolase inhibitors | ARRAY BIOPHARMA INC. (US) | 2009-08-20 | — | — | US | disclosed |
| US-20090209554-A1 | Thiazoliums as transketolase inhibitors | ARRAY BIOPHARMA INC. (US) | 2009-08-20 | — | — | US | disclosed |
| US-20090209554-A1 | Thiazoliums as transketolase inhibitors | ARRAY BIOPHARMA INC. (US) | 2009-08-20 | — | — | US | disclosed |
| US-7498445-B2 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | RENOPHARM LTD. (IL) | 2009-03-03 | — | — | US | disclosed |
| US-7498445-B2 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | RENOPHARM LTD. (IL) | 2009-03-03 | — | — | US | disclosed |
| US-7498445-B2 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | RENOPHARM LTD. (IL) | 2009-03-03 | — | — | US | disclosed |
| US-20080242863-A1 | Process For the Manufacture of a Precursor of Vitamin B1 | DSM IP ASSETS B.V. (NL) | 2008-10-02 | — | — | US | disclosed |
| US-20080233163-A1 | Thiazole-based Nitric Oxide donors having Acyl substuent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-09-25 | — | — | US | disclosed |
| US-20080233163-A1 | Thiazole-based Nitric Oxide donors having Acyl substuent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-09-25 | — | — | US | disclosed |
| US-20080233163-A1 | Thiazole-based Nitric Oxide donors having Acyl substuent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-09-25 | — | — | US | disclosed |
| EP-1841745-B1 | PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1 | DSM IP ASSETS BV (NL) | 2008-06-04 | — | — | EP | disclosed |
| US-7368577-B2 | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-05-06 | — | — | US | disclosed |
| US-7368577-B2 | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-05-06 | — | — | US | disclosed |
| US-7368577-B2 | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-05-06 | — | — | US | disclosed |
| US-7332513-B2 | Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-02-19 | — | — | US | disclosed |
| US-7332513-B2 | Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-02-19 | — | — | US | disclosed |
| US-7332513-B2 | Thiazole-based nitric oxide donors having acyl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2008-02-19 | — | — | US | disclosed |
| US-20070293501-A1 | Thioalkeneamides as Transketolase Inhibitors | ARRAY BIOPHARMA INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-20070293501-A1 | Thioalkeneamides as Transketolase Inhibitors | ARRAY BIOPHARMA INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-20070293501-A1 | Thioalkeneamides as Transketolase Inhibitors | ARRAY BIOPHARMA INC. (US) | 2007-12-20 | — | — | US | disclosed |
| EP-1841745-A2 | PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1 | DSMIP Assets B.V. (NL) | 2007-10-10 | — | — | EP | disclosed |
| US-7189750-B2 | Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof | RENOPHARM LTD. (IL) | 2007-03-13 | — | — | US | disclosed |
| US-7189750-B2 | Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof | RENOPHARM LTD. (IL) | 2007-03-13 | — | — | US | disclosed |
| US-7189750-B2 | Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof | RENOPHARM LTD. (IL) | 2007-03-13 | — | — | US | disclosed |
| EP-1753734-A1 | NITRIC OXIDE DONORS AND USES THEREOF | RENOPHARM LTD. (IL) | 2007-02-21 | — | — | EP | disclosed |
| US-20070021382-A1 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2007-01-25 | — | — | US | disclosed |
| US-20070021382-A1 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2007-01-25 | — | — | US | disclosed |
| US-20070021382-A1 | Nitric oxide donors and uses thereof | RENOPHARM LTD. (IL) | 2007-01-25 | — | — | US | disclosed |
| US-20060183718-A1 | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof | RENOPHARM LTD. (IL) | 2006-08-17 | — | — | US | disclosed |
| US-20060183913-A1 | Thiazole-based nitric oxide donors having acyl substuent(s) and uses thereof | RENOPHARM LTD. (IL) | 2006-08-17 | — | — | US | disclosed |
| US-20060183912-A1 | Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof | RENOPHARM LTD. (IL) | 2006-08-17 | — | — | US | disclosed |
| WO-2006079504-A2 | PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1 | DSM IP ASSETS B.V. (NL) | 2006-08-03 | — | — | WO | disclosed |
| US-20060069139-A1 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | RENOPHARM LTD. (IL) | 2006-03-30 | — | — | US | disclosed |
| US-20060069138-A1 | Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof | RENOPHARM LTD. (IL) | 2006-03-30 | — | — | US | disclosed |
| WO-2005105765-A1 | NITRIC OXIDE DONORS AND USES THEREOF | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005105065-A2 | THIAZOLE-BASED NITRIC OXIDE DONORS FOR TREATING INFLAMMATORY BOWEL DISEASES | RENOPHARM LTD. (IL) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005095344-A1 | THIOALKENEAMIDES AS TRANSKETOLASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005095391-A1 | THIAZOLIUMS AS TRANSKETOLASE INHIBITORS | ARRAY BIOPHARMA INC. (US) | 2005-10-13 | — | — | WO | disclosed |
| JP-2004026671-A | METHOD FOR MANUFACTURING THIAZOLE COMPOUNDS | DAITO KAGAKU KK | 2004-01-29 | — | — | JP | disclosed |
| EP-0037474-B1 | PROCESS FOR THE PREPARATION OF 1-ACETOXY-3-CHLORO-PENTANONE-4 | BASF Aktiengesellschaft (DE) | 1983-04-06 | — | — | EP | disclosed |
| EP-0037474-B1 | PROCESS FOR THE PREPARATION OF 1-ACETOXY-3-CHLORO-PENTANONE-4 | BASF Aktiengesellschaft (DE) | 1983-04-06 | — | — | EP | disclosed |
| EP-0037474-A1 | Process for the preparation of 1-acetoxy-3-chloro-pentanone-4 | BASF Aktiengesellschaft (DE) | 1981-10-14 | — | — | EP | disclosed |
| EP-0037474-A1 | Process for the preparation of 1-acetoxy-3-chloro-pentanone-4 | BASF Aktiengesellschaft (DE) | 1981-10-14 | — | — | EP | disclosed |
| EP-0037474-A1 | Process for the preparation of 1-acetoxy-3-chloro-pentanone-4 | BASF Aktiengesellschaft (DE) | 1981-10-14 | — | — | EP | disclosed |
| EP-0037474-A1 | Process for the preparation of 1-acetoxy-3-chloro-pentanone-4 | BASF Aktiengesellschaft (DE) | 1981-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (16 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090209554-A1 | Thiazoliums as transketolase inhibitors | TKT, RRM2, TYMS | ALOX15 3979/4885ALDH1A1 766/4885CHRNB2 4821/4885 |
| US-20080242863-A1 | Process For the Manufacture of a Precursor of Vitamin B1 | ADH1B, SLC19A2, ADH4 | ALOX15 278/4885ALDH1A1 107/4885CHRNB2 2699/4885 |
| US-20210355070-A1 | METHOD FOR PREPARING 3-CHLORO-4-OXOPENTYL ACETATE USING FULLY CONTINUOUS-FLOW MICRO-REACTION SYSTEM | ACACA, ACACB, MCCC2 | ALOX15 1103/4885ALDH1A1 305/4885CHRNB2 343/4885 |
| US-20080233163-A1 | Thiazole-based Nitric Oxide donors having Acyl substuent(s) and uses thereof | NOS2, NOS1, SQOR | ALOX15 96/4885ALDH1A1 240/4885CHRNB2 3484/4885 |
| US-20060183912-A1 | Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof | NOS2, NOS1, NOS3 | ALOX15 395/4885ALDH1A1 274/4885CHRNB2 2867/4885 |
| US-20230183196-A1 | FULL CONTINUOUS-FLOW PREPARATION METHOD OF VITAMIN B1 | SLC19A2, VKORC1, VKORC1L1 | ALOX15 112/4885ALDH1A1 390/4885CHRNB2 2613/4885 |
| US-20110178300-A1 | NOVEL SYNTHESIS OF SUBSTITUTED 4-AMINO-PYRIMIDINES | IL4I1, CCNB1, VKORC1 | ALOX15 1214/4885ALDH1A1 831/4885CHRNB2 2092/4885 |
| US-20060183718-A1 | Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof | NOS2, NOS1, NOS3 | ALOX15 325/4885ALDH1A1 202/4885CHRNB2 2858/4885 |
| US-11834425-B2 | Full continuous-flow preparation method of vitamin B1 | SLC19A2, CYP2S1, CBS | ALOX15 399/4885ALDH1A1 670/4885CHRNB2 1607/4885 |
| US-20060183913-A1 | Thiazole-based nitric oxide donors having acyl substuent(s) and uses thereof | NOS2, NOS1, SQOR | ALOX15 96/4885ALDH1A1 240/4885CHRNB2 3484/4885 |
| US-20250129021-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, NRAS | ALOX15 2521/4885ALDH1A1 2630/4885CHRNB2 4827/4885 |
| US-11618727-B2 | Method for preparing 3-chloro-4-oxopentyl acetate using fully continuous-flow micro-reaction system | ACACA, ACACB, MCCC2 | ALOX15 1103/4885ALDH1A1 305/4885CHRNB2 343/4885 |
| US-20070293501-A1 | Thioalkeneamides as Transketolase Inhibitors | TKT, AKR1A1, RRM2 | ALOX15 1675/4885ALDH1A1 132/4885CHRNB2 4859/4885 |
| US-20060069139-A1 | Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof | NOS2, NOS1, NOS3 | ALOX15 292/4885ALDH1A1 337/4885CHRNB2 2141/4885 |
| US-20070021382-A1 | Nitric oxide donors and uses thereof | NOS2, NOS1, NOS3 | ALOX15 111/4885ALDH1A1 475/4885CHRNB2 1474/4885 |
| US-20060069138-A1 | Thiazole-based nitric oxide donors having alkyl substuent(s) and uses thereof | NOS1, NOS2, NOS3 | ALOX15 88/4885ALDH1A1 204/4885CHRNB2 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.